|Lotronex Information Center|
November 29, 2000
Lotronex pulled from market
After meetings with Food and Drug Administration (FDA), Glaxo Wellcome has made the decision to pull Lotronex (alosetron hydrochloride) from the market.
October 31, 2000
Death Reports Prompt Another FDA Probe Of Lotronex
The Food and Drug Administration (FDA) is reviewing the safety of Lotronex after reports that five women died after using the medication.
August 25, 2000
Tougher Warnings on Lotronex
US officials are now requiring consumer-friendly information about the possible side effects of Lotronex to be distributed. Warnings on the drug are also being strengthened.
FDA Press Releases and Documents
June 27, 2000
Gastrointestinal Drugs Advisory Committee Meeting
Transcripts, briefing information, and questions for discussion from the Gastrointestinal Drugs Advisory Committee meeting regarding adverse affects to Lotronex.
Glaxo Wellcome Inc. Press Releases and Documents
Lotronex Patient Information
PharmInfoNet DrugFAQs: Lotronex (alosetron)
A few questions and answers about Lotronex, including some special warnings and general precautions.
RxList Alosetron (Lotronex®) FAQ
Includes a description, medication interactions, side effects, and warnings for Lotronex.
Reporting Adverse Reactions
How to Report Adverse Reactions & Medical Product Problems to the FDA
"FDA encourages anyone aware of a serious adverse reaction (to Lotronex), including consumers, to make a MedWatch report."